Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats
Purpose: This study aims to investigate the effect of edaravone in preventing cisplatin-induced brain damage. Methods: Forty female Wistar albino rats were included in the study. 4 groups were created. In group 1 (control group) (n=10), neither any drugs were given nor anything was performed. Group...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Acta Neurologica Taiwanica |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103//ANT.33-1_111_0067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849471770532249600 |
|---|---|
| author | Ozlem Kara Asuman Kilitci |
| author_facet | Ozlem Kara Asuman Kilitci |
| author_sort | Ozlem Kara |
| collection | DOAJ |
| description | Purpose:
This study aims to investigate the effect of edaravone in preventing cisplatin-induced brain damage.
Methods:
Forty female Wistar albino rats were included in the study. 4 groups were created. In group 1 (control group) (n=10), neither any drugs were given nor anything was performed. Group 2 (cisplatin group) (n=10), single dose 7.5 mg/kg cisplatin was given. In group 3 (edaravone group) (n=10), single dose 1 mg/kg edaravone was administered. Group 4 (cisplatin+ edaravone group) (n=10), single dose 7.5 mg/kg cisplatin and 1 mg/kg edaravone were given. Brain tissue was removed in all rats after 3 days. Blood samples taken from heart tissue were examined for malondialdehyde (MDA) and nitric oxide (NO) levels. Brain tissue was evaluated for damage with p53, GFAP and Ki 67.
Results:
Edaravone reduced cisplatin-induced brain damage. MDA and NO levels in the cisplatin group were significantly higher than the other groups (p< 0.05). Likewise, tissue damage in the cisplatin group was significantly higher than in the other groups (p< 0.05). The immunohistochemical staining which was done by using p53, GFAP and Ki 67 was shown that tissue damage was higher in cisplatin group than cisplatin+ edaravone group and this difference was found to be statistically significant (p< 0.05).
Conclusion:
The findings of our study suggest that edaravone therapy may be effective in the prevention and treatment of cisplatin-induced brain injury. |
| format | Article |
| id | doaj-art-b3a7875a3a9e4fefa71a3bd1162561eb |
| institution | Kabale University |
| issn | 1028-768X |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Acta Neurologica Taiwanica |
| spelling | doaj-art-b3a7875a3a9e4fefa71a3bd1162561eb2025-08-20T03:24:43ZengWolters Kluwer Medknow PublicationsActa Neurologica Taiwanica1028-768X2024-01-0133191210.4103//ANT.33-1_111_0067Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in RatsOzlem KaraAsuman KilitciPurpose: This study aims to investigate the effect of edaravone in preventing cisplatin-induced brain damage. Methods: Forty female Wistar albino rats were included in the study. 4 groups were created. In group 1 (control group) (n=10), neither any drugs were given nor anything was performed. Group 2 (cisplatin group) (n=10), single dose 7.5 mg/kg cisplatin was given. In group 3 (edaravone group) (n=10), single dose 1 mg/kg edaravone was administered. Group 4 (cisplatin+ edaravone group) (n=10), single dose 7.5 mg/kg cisplatin and 1 mg/kg edaravone were given. Brain tissue was removed in all rats after 3 days. Blood samples taken from heart tissue were examined for malondialdehyde (MDA) and nitric oxide (NO) levels. Brain tissue was evaluated for damage with p53, GFAP and Ki 67. Results: Edaravone reduced cisplatin-induced brain damage. MDA and NO levels in the cisplatin group were significantly higher than the other groups (p< 0.05). Likewise, tissue damage in the cisplatin group was significantly higher than in the other groups (p< 0.05). The immunohistochemical staining which was done by using p53, GFAP and Ki 67 was shown that tissue damage was higher in cisplatin group than cisplatin+ edaravone group and this difference was found to be statistically significant (p< 0.05). Conclusion: The findings of our study suggest that edaravone therapy may be effective in the prevention and treatment of cisplatin-induced brain injury.https://journals.lww.com/10.4103//ANT.33-1_111_0067cisplatinedaravoneapoptosisbrainrat |
| spellingShingle | Ozlem Kara Asuman Kilitci Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats Acta Neurologica Taiwanica cisplatin edaravone apoptosis brain rat |
| title | Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats |
| title_full | Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats |
| title_fullStr | Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats |
| title_full_unstemmed | Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats |
| title_short | Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats |
| title_sort | antioxidant and apoptotic effect of edaravone on cisplatin induced brain injury in rats |
| topic | cisplatin edaravone apoptosis brain rat |
| url | https://journals.lww.com/10.4103//ANT.33-1_111_0067 |
| work_keys_str_mv | AT ozlemkara antioxidantandapoptoticeffectofedaravoneoncisplatininducedbraininjuryinrats AT asumankilitci antioxidantandapoptoticeffectofedaravoneoncisplatininducedbraininjuryinrats |